Fig. 5From: Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts modelPercentage of CAFs and tumors receiving ≥ 10% of the maximum Dabs within the SM across the five models using either tumor cells or CAFs as sources or targets for 177Lu and 225Ac. Values for 177Lu S(vTumors ← vTumors), S(VCAF ← VCAF) and S(VCAF ← VTumors) are superposedBack to article page